Prot #R668-AD-1836: AAD-PEPR: Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments: Clinically Relevant Endpoints in Atopic Dermatitis in Children (CREAD-C)

Project: Research project

Project Details

StatusActive
Effective start/end date1/15/191/31/22

Funding

  • Regeneron Pharmaceuticals, Inc. (Prot #R668-AD-1836)